124 related articles for article (PubMed ID: 23817209)
1. Time to positivity as prognostic tool in patients with Pseudomonas aeruginosa bloodstream infection.
Willmann M; Kuebart I; Vogel W; Flesch I; Markert U; Marschal M; Schröppel K; Autenrieth IB; Hölzl F; Peter S
J Infect; 2013 Nov; 67(5):416-23. PubMed ID: 23817209
[TBL] [Abstract][Full Text] [Related]
2. Time-to-positivity of blood culture: An independent prognostic factor of monomicrobial Pseudomonas aeruginosa bacteremia.
Tang PC; Lee CC; Li CW; Li MC; Ko WC; Lee NY
J Microbiol Immunol Infect; 2017 Aug; 50(4):486-493. PubMed ID: 26455486
[TBL] [Abstract][Full Text] [Related]
3. Effect of metallo-β-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosa bloodstream infection: a retrospective cohort study.
Willmann M; Kuebart I; Marschal M; Schröppel K; Vogel W; Flesch I; Markert U; Autenrieth IB; Hölzl F; Peter S
BMC Infect Dis; 2013 Nov; 13():515. PubMed ID: 24176052
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the systemic inflammatory response syndrome between monomicrobial and polymicrobial Pseudomonas aeruginosa nosocomial bloodstream infections.
Marra AR; Bearman GM; Wenzel RP; Edmond MB
BMC Infect Dis; 2005 Oct; 5():94. PubMed ID: 16259623
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of time to positivity of blood culture in children with Pseudomonas aeruginosa bacteremia.
Xu H; Cheng J; Yu Q; Li Q; Yi Q; Luo S; Li Y; Zhang G; Tian X; Cheng D; Luo Z
BMC Infect Dis; 2020 Sep; 20(1):665. PubMed ID: 32907533
[TBL] [Abstract][Full Text] [Related]
6. Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa.
Marra AR; Bearman GM; Wenzel RP; Edmond MB
BMC Infect Dis; 2006 Aug; 6():132. PubMed ID: 16916466
[TBL] [Abstract][Full Text] [Related]
7. A model to predict mortality following Pseudomonas aeruginosa bacteremia.
Hirsch EB; Cottreau JM; Chang KT; Caeiro JP; Johnson ML; Tam VH
Diagn Microbiol Infect Dis; 2012 Jan; 72(1):97-102. PubMed ID: 22056006
[TBL] [Abstract][Full Text] [Related]
8. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa.
Marra AR; Bar K; Bearman GM; Wenzel RP; Edmond MB
J Infect; 2006 Jul; 53(1):30-5. PubMed ID: 16253333
[TBL] [Abstract][Full Text] [Related]
9. Time-to-positivity in patients with Escherichia coli bacteraemia.
Peralta G; Roiz MP; Sánchez MB; Garrido JC; Ceballos B; Rodríguez-Lera MJ; Mateos F; De Benito I
Clin Microbiol Infect; 2007 Nov; 13(11):1077-82. PubMed ID: 17727685
[TBL] [Abstract][Full Text] [Related]
10. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.
Johnson LE; D'Agata EM; Paterson DL; Clarke L; Qureshi ZA; Potoski BA; Peleg AY
Transpl Infect Dis; 2009 Jun; 11(3):227-34. PubMed ID: 19302282
[TBL] [Abstract][Full Text] [Related]
12. Tree-structured survival analysis of patients with Pseudomonas aeruginosa bacteremia: A multicenter observational cohort study.
Yoon YK; Kim HA; Ryu SY; Lee EJ; Lee MS; Kim J; Park SY; Yang KS; Kim SW;
Diagn Microbiol Infect Dis; 2017 Feb; 87(2):180-187. PubMed ID: 27863948
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy.
Tuon FF; Gortz LW; Rocha JL
Braz J Infect Dis; 2012; 16(4):351-6. PubMed ID: 22846123
[TBL] [Abstract][Full Text] [Related]
14. Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the ED.
Kang CI; Chung DR; Peck KR; Song JH;
Am J Emerg Med; 2012 Sep; 30(7):1169-75. PubMed ID: 22030178
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections.
Suárez C; Peña C; Tubau F; Gavaldà L; Manzur A; Dominguez MA; Pujol M; Gudiol F; Ariza J
J Infect; 2009 Apr; 58(4):285-90. PubMed ID: 19297028
[TBL] [Abstract][Full Text] [Related]
16. A specific serum IgA antibody discriminates pneumonia from colonization state in patients with Pseudomonas aeruginosa in sputum culture.
Yamashita M; Hida Y; Sugimoto H; Takahashi N; Kimura H; Nakatomi Y; Yoshida H; Ishizaki T
J Microbiol Methods; 2010 Sep; 82(3):198-204. PubMed ID: 20538018
[TBL] [Abstract][Full Text] [Related]
17. Time to positivity of blood culture and its prognostic value in bloodstream infection.
Ning Y; Hu R; Yao G; Bo S
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):619-24. PubMed ID: 26825316
[TBL] [Abstract][Full Text] [Related]
18. Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection.
Khatib R; Riederer K; Saeed S; Johnson LB; Fakih MG; Sharma M; Tabriz MS; Khosrovaneh A
Clin Infect Dis; 2005 Sep; 41(5):594-8. PubMed ID: 16080079
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between in vitro bacterial growth velocity of blood of patients with clinical parameters and prognosis in patients with Escherichia coli bacteremia].
Bo SN; Ning YZ; Zhu X; Yao GQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Sep; 22(9):533-6. PubMed ID: 20854732
[TBL] [Abstract][Full Text] [Related]
20. Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective cohort study.
Liao CH; Lai CC; Hsu MS; Huang YT; Chu FY; Hsu HS; Hsueh PR
Clin Microbiol Infect; 2009 Dec; 15(12):1119-25. PubMed ID: 19392886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
